Core Viewpoint - Beyond Meat, Inc. is under investigation for potential violations of federal securities laws, particularly concerning the inflation of the value of certain long-lived assets [2][5]. Group 1: Company Operations and Financials - Beyond Meat underwent a global operations review in late 2023, leading to the depreciation of certain long-lived assets, which were recorded at the lower of their carrying value or fair value less costs to sell, with no impairments reported [4]. - On October 24, 2025, Beyond Meat announced an expected non-cash impairment charge for the three months ended September 27, 2025, related to certain long-lived assets, which was anticipated to be material [6]. - The company delayed its earnings announcement for Q3 2025 on November 3, 2025, due to the need for additional time to complete the impairment review, resulting in a significant decline in stock price during that trading day [7]. Group 2: Stock Performance - Following the announcement of the expected impairment charge, Beyond Meat's stock price dropped approximately 23%, from $2.84 per share on October 23, 2025, to $2.185 per share on October 24, 2025 [6].

Core Viewpoint - A lawsuit has been filed against MoonLake Immunotherapeutics for potential violations of federal securities laws, with a significant deadline for investors to act by December 15, 2025 [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Peters v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08612 [3]. - Investors are encouraged to contact BFA Law for more information and to potentially lead the case [2][8]. Group 2: Company Background - MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases [4]. - The company conducted Phase 3 VELA trials for sonelokimab (SLK), aimed at treating moderate to severe hidradenitis suppurativa [4]. Group 3: Allegations and Impact - The complaint alleges that MoonLake misrepresented its clinical data and the benefits of SLK's Nanobody structure compared to traditional monoclonal antibody treatments [5][6]. - Following the announcement of disappointing results from the VELA trials on September 28, 2025, MoonLake's stock price plummeted nearly 90%, from $61.99 to $6.24 per share [7].

Core Viewpoint - RCI Hospitality Holdings, Inc. is facing a securities fraud class action lawsuit due to allegations of tax fraud and bribery involving its executives, which has resulted in a significant drop in its stock price [2][3][4]. Summary by Sections Company Overview - RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is under scrutiny following the indictment of its top executives for involvement in a multimillion-dollar criminal tax fraud and bribery scheme [2]. Legal Proceedings - A class action lawsuit has been filed on behalf of investors who acquired RCI securities between December 15, 2021, and September 16, 2025, with a deadline of November 20, 2025, to participate as a lead plaintiff [1][5]. Allegations - The lawsuit alleges that RCI's executives made materially false and misleading statements and failed to disclose significant adverse facts about the company's operations, including: 1. Engagement in tax fraud 2. Bribery to conceal tax fraud 3. Understated legal risks facing the company 4. Misleading positive statements regarding the company's business and prospects [4]. Market Impact - Following the announcement of the indictments on September 16, 2025, RCI's stock price fell by $5.53, or 15.9%, closing at $28.79, which has adversely affected investors [3].

Core Viewpoint - Iron Mountain Inc. is under investigation for potential securities law violations following a report from Gotham City Research that alleges the company has understated its leverage and inflated adjusted EBITDA, while also facing customer lawsuits regarding fee increases and aggressive practices [2][4]. Group 1: Company Allegations - Gotham City Research claims that Iron Mountain has understated its leverage and inflated adjusted EBITDA through recurring add-backs [2]. - The report also highlights customer lawsuits accusing Iron Mountain of imposing sharply higher fees and engaging in "ransom-like" practices related to record retrieval and destruction [2]. Group 2: Investigation and Legal Actions - Block & Leviton is investigating Iron Mountain for potential securities law violations and may file an action to recover losses for affected investors [4]. - Investors who have lost money on their Iron Mountain investments are encouraged to contact Block & Leviton for more information on recovery options [3][5]. Group 3: Whistleblower Information - Individuals with non-public information about Iron Mountain are encouraged to assist in the investigation or report to the SEC under the whistleblower program, with potential rewards of up to 30% of any successful recovery [6]. Group 4: Firm Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Nov 19, 2025 12:06 PM Eastern Standard Time Law Offices of Frank R. Cruz Encourages Perrigo Company plc (PRGO) Shareholders To Inquire About Securities Fraud Class Action Share IF YOU SUFFERED A LOSS ON YOUR PERRIGO COMPANY PLC (PRGO) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit ...

Core Viewpoint - Jefferies Financial Group Inc. and its trade finance arm Point Bonita Capital are under investigation for potential violations of federal securities laws related to their significant exposure to First Brands Group, which recently filed for bankruptcy [1][2][4]. Group 1: Company Overview - Jefferies is an investment banking and capital markets firm, while Point Bonita Capital serves as its trade finance division [2]. - Both firms were closely associated with First Brands Group, an auto parts supplier that declared bankruptcy in September 2025 [2]. Group 2: Financial Exposure - On October 8, 2025, Jefferies disclosed that it and Point Bonita had approximately $715 million in exposure to First Brands' receivables, accounting for about 25% of Point Bonita's trade finance portfolio [3]. - Following this announcement, Jefferies' stock price dropped by $4.66 per share, or approximately 8%, from $59.10 on October 7, 2025, to $54.44 on October 8, 2025 [3]. Group 3: Legal Investigation - Bleichmar Fonti & Auld LLP is investigating whether Jefferies and/or Point Bonita made materially false and misleading statements to investors regarding their exposure to First Brands [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Quanex Building Products Corporation during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Quanex securities between December 12, 2024, and September 5, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3][6]. - The lawsuit claims that Quanex made false and misleading statements regarding its operations, particularly concerning the maintenance of tooling and equipment at its Tyman Mexico facility, which were significantly underinvested [5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering substantial amounts for investors [4]. - The firm has been recognized for its achievements in securities class action settlements, including a notable settlement against a Chinese company and ranking highly in the number of settlements achieved [4]. Group 3: Case Specifics - The lawsuit alleges that Quanex's tooling and equipment conditions had degraded to near catastrophic levels, leading to significant costs and delays in expected benefits from the Tyman integration [5]. - It is claimed that Quanex had previously identified these issues, and the positive statements made by the defendants about the company's business were materially misleading [5].

Core Viewpoint - The Schall Law Firm is investigating potential securities law violations by Ardent Health, Inc., focusing on misleading statements and undisclosed information that may have affected investors [2]. Financial Impact - Ardent Health, Inc. reported a $43 million reduction in revenue due to accounting changes and a $54 million increase in professional liability reserves in its Q3 2025 financial results [2]. - Following this announcement, Ardent's shares fell nearly 34% the next day [2]. Legal Action - The Schall Law Firm is encouraging shareholders who suffered losses to participate in the investigation and discuss their rights [3].

Core Viewpoint - Stride, Inc. is facing a securities fraud class action lawsuit due to allegations of misleading statements and omissions regarding its products and services, which have resulted in significant financial losses for investors [3][4][5]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased Stride securities from October 22, 2024, to October 28, 2025, alleging that the company inflated enrollment numbers and cut staff costs beyond statutory limits while ignoring compliance requirements [3]. Allegations and Impact - A complaint was filed by the Gallup-McKinley County Schools Board of Education against Stride, alleging fraud and deceptive practices, including retaining "ghost students" to secure state funding, which led to a significant drop in share price by approximately 11.7% [4]. - On October 28, 2025, Stride reported that "poor customer experience" resulted in an estimated 10,000-15,000 fewer enrollments, causing a dramatic decline in share price by approximately 54.4% [5]. Investor Actions - Investors who suffered losses on their Stride investments have until January 12, 2026, to request lead plaintiff appointment in the class action lawsuit [2].

Core Points - A class action lawsuit has been filed against Perrigo Company plc for alleged securities fraud and unlawful business practices [1] - Investors who purchased Perrigo securities during the Class Period can apply to be Lead Plaintiff by January 16, 2026 [2] - Perrigo reported significant financial challenges, including a 50% decline in earnings per share for fiscal year 2023 due to remediation costs in its infant formula business [2] - The company's stock price has experienced significant declines following negative earnings reports and strategic announcements, including a drop of 25.2% to close at $15.10 per share on November 5, 2025, after announcing a strategic review of its infant formula business [3] Financial Performance - For fiscal year 2023, Perrigo incurred one-time cash costs of $35 million to $45 million related to production issues in its infant formula business [2] - The adjusted gross profit for the second quarter ended June 28, 2025, decreased by $30 million, or 6.9%, attributed to production variability in infant formula [3] - The stock price fell by $4.87 per share (15.14%) on February 27, 2024, and by $3.28 per share (9.8%) on May 7, 2024, following negative earnings reports [2][3]